Tuberculosis Testing: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Tuberculosis Testing Market: By Type (Culture Based Tests, Chest X-Ray, Mantoux Test (TST), Interferon Gamma Release Analysis (IGRA), Nucleic Acid Testing, Sear Microscopy, Serological Tests), By End User (Hospitals, Diagnostic Centres, Others), and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global tuberculosis testing market size was valued at US$ 3.02 Bn in 2020 and is anticipated to expand at a CAGR of 4.5% from 2021 to 2027. Tuberculosis is a bacterial infectious disease caused by Mycobacterium tuberculosis (MTB). Tuberculosis spreads through air and direct contact with the infected sputum. Tuberculosis usually affects lungs. But it can affect any other parts of the body. Tuberculosis patient generally experiences symptoms such as cough, chills, fever, fatigue, loss of weight and others. TB infecting bones can lead to joint destruction or spinal pain. The most common diagnostic test used for TB is skin test, but it is not fully accurate. There are many tuberculosis tests are available such as blood test, sputum tests, and Chest X-rays. The tuberculosis testing market is consolidated with the presence of strong market key players involving in development and marketing of the tuberculosis tests. Companies adopting the strategies such as mergers and acquisitions to strengthen their market position and expand their global reach. For instance, in October 2017, Abbot Laboratories has acquired Alere Inc., to become a leading market player in point of care testing and advance its geographical reach. Furthermore, market layers also developing new testing technologies and novel products to increase their market share. For instance, in Feb 2012, Quanterix Corporation collaborated with the Forsyth Institute and Beth Israel Deaconess Medical Center (BIDMC) to develop the fast and simple test for accurate diagnosis of tuberculosis.

Tuberculosis Testing Market

MARKET SUMMARY
-
4.5% CAGR
  • Study Period– 2021 – 2026
  • Base Year– 2020
  • CAGR– 4.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Tuberculosis Testing Market

  • The report on global tuberculosis testing market gives historical, current and future market sizes (US$ Bn) based on the test type, end-user and region.
  • tuberculosis testing market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Hologic, Inc.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • bioMerieux SA (Institut Mérieux)
Drivers And Restraints

Tuberculosis Testing Market

Primary drivers for the global tuberculosis testing market include the rise in the disease prevalence worldwide. In addition, technological advancements in tuberculosis testing such as advent of test kits and point of care products are expected to boost the global tuberculosis testing market over the forecast period. Furthermore, government initiatives for early detection and of tuberculosis coupled with an increase in adaptation of the point of care products for tuberculosis diagnosis are expected to boost the market growth over the forecast period. However, R&D cost for the development of the novel testing procedures for TB expected to hamper the market growth over the coming years.


North-America got significant share

Tuberculosis Testing Market

Geographically tuberculosis testing market is divided into five key regions, i.e. Europe, North America, Latin America, Asia- Pacific, and The Middle East & Africa. North America tuberculosis testing market expected to have the significant market share owing to the presence of key market players, and developed healthcare infrastructure. Furthermore, market is witnessing recent product launched and strategical collaboration and acquisitions especially in U.S. For instance, In October 2017, Qiagen has launched QuantiFERON TB Gold Plus, blood test for the tuberculosis (TB) infections in U.S. market. Europe tuberculosis testing market expected to show notable growth rates owing to the prevalence of tuberculosis, technological advancements in the diagnostic tests coupled with the growing awareness related to early diagnosis and treatment of TB. World Health Organization, estimates that about 323000 new TB cases were reported in the Europe, in 2015. Asia Pacific tuberculosis testing market is projected to have lucrative growth opportunity due to the disease prevalence, developing healthcare infrastructure and initiatives taken by the government to increase awareness and funding for early detection of tuberculosis.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In March 2017, Rutgers New Jersey Medical School and FIND launched Xpert MTB/RIF Ultra, for the diagnosis of TB and rifampicin resistance.

Key

Key Features of the Report

Tuberculosis Testing Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Hologic, Inc. (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Abbott Laboratories (U.S.)
  • bioMerieux SA (Institut Mérieux) (France)
  • Hoffmann-La Roche AG (Switzerland)
  • Cepheid (The Danaher Corporation) (U.S.)
  • Sanofi S.A. (France)
  • QIAGEN (Germany)
  • Hain Lifescience GmbH (Germany)

Description

The global tuberculosis testing market size was valued at US$ 3.02 Bn in 2020 and is anticipated to expand at a CAGR of 4.5% from 2021 to 2027. Tuberculosis is a bacterial infectious disease caused by Mycobacterium tuberculosis (MTB). Tuberculosis spreads through air and direct contact with the infected sputum. Tuberculosis usually affects lungs. But it can affect any other parts of the body. Tuberculosis patient generally experiences symptoms such as cough, chills, fever, fatigue, loss of weight and others. TB infecting bones can lead to joint destruction or spinal pain. The most common diagnostic test used for TB is skin test, but it is not fully accurate. There are many tuberculosis tests are available such as blood test, sputum tests, and Chest X-rays. The tuberculosis testing market is consolidated with the presence of strong market key players involving in development and marketing of the tuberculosis tests. Companies adopting the strategies such as mergers and acquisitions to strengthen their market position and expand their global reach. For instance, in October 2017, Abbot Laboratories has acquired Alere Inc., to become a leading market player in point of care testing and advance its geographical reach. Furthermore, market layers also developing new testing technologies and novel products to increase their market share. For instance, in Feb 2012, Quanterix Corporation collaborated with the Forsyth Institute and Beth Israel Deaconess Medical Center (BIDMC) to develop the fast and simple test for accurate diagnosis of tuberculosis.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX